NASDAQ: CURX
Curanex Pharmaceuticals Inc Earnings Dates, Reports, Calls

Curanex Pharmaceuticals earnings were N/A for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CURX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$137.6k, up 0.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CURX reported annual earnings of -$361.5k, with 1,783% growth.

CURX earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

CURX Return on Equity

Insufficient data to display

CURX undefined

Insufficient data to display

Be the first to know when CURX announces earnings.

CURX undefined

Current Company
0%
Current Industry
5.8%

CURX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AAPGN/A-$161.45MN/A-$2.02
AARDN/AN/AN/AN/A
ABCL-$113.80M-$167.87MN/A-$0.56
ABVXN/AN/AN/AN/A
ACET-$107.56M-$117.32MN/A-$1.29

Curanex Pharmaceuticals Earnings Reports & History FAQ

What were Curanex Pharmaceuticals's earnings last quarter?

Curanex Pharmaceuticals (NASDAQ: CURX) reported Q1 2025 earnings per share (EPS) of -$0.01, up 92.31% year over year. Total CURX earnings for the quarter were -$137.58 thousand. In the same quarter last year, Curanex Pharmaceuticals's earnings per share (EPS) was -$0.13.

If you're new to stock investing, here's how to buy Curanex Pharmaceuticals stock.

Is Curanex Pharmaceuticals profitable or losing money?

As of the last Curanex Pharmaceuticals earnings report, Curanex Pharmaceuticals is currently losing money. Curanex Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was N/A, a N/A decrease year over year.

What was CURX's earnings growth in the past year?

As of Curanex Pharmaceuticals's earnings date in Q3 2025, Curanex Pharmaceuticals's earnings has grown year over year. CURX earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.